Guide for patients & caregivers
Negative Hepatitis B Surface Antibody After Vaccination: What Does It Mean?
Negative hepatitis B surface antibody after vaccination? Learn about non-responders, waning levels, repeat courses, healthcare-worker checks and what to ask.
Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles
What does a negative hepatitis B surface antibody mean after vaccination?
A negative hepatitis B surface antibody (anti-HBs) result after vaccination means the test did not find antibody at or above the level counted as protective, usually 10 mIU/mL in CDC guidance. If the test was done 1–2 months after finishing the course, it may mean the vaccine has not yet produced protection. If it was done years later, it often reflects normal waning rather than lost protection.
This guide is for adults reviewing an anti-HBs result, often for work in healthcare. It explains how clinicians usually think about the result. It cannot tell you whether you are protected; that depends on your records, timing and the full set of hepatitis B tests.
When to get checked sooner
If you have a needlestick injury, a bite, or blood or body fluid splashes into your eyes, mouth or broken skin, report it straight away to occupational health, your supervisor, or local urgent or emergency services. Do not wait for a routine appointment. CDC guidance sets out post-exposure assessment that depends on your vaccine response and the source person's status, and the NHS notes that vaccination can be part of the response after an exposure.
Seek medical advice promptly if you develop possible signs of hepatitis, such as yellowing of the skin or the whites of the eyes (jaundice), dark urine, pale stools, tiredness, a high temperature, feeling or being sick, or pain in the upper tummy. These symptoms need assessment whatever your antibody result.
What is anti-HBs, and how is it different from other hepatitis B tests?
MedlinePlus describes anti-HBs as an antibody the immune system makes against the hepatitis B virus after infection or after vaccination. It is a marker of immunity, not of current infection.
Other markers answer different questions. Hepatitis B surface antigen (HBsAg) shows whether the virus is present now. Hepatitis B core antibody (anti-HBc), which MedlinePlus says is made only after a hepatitis B infection, points to past or current infection rather than vaccination. If your report includes these, read them together rather than focusing on anti-HBs alone.
Why do some people not respond to the hepatitis B vaccine?
The vaccine works well for most people. The NHS states that about 90% of adults have good protection after vaccination, and CDC guidance reports protection in more than 90% of healthy adults under 40, with lower rates at older ages.
CDC sources list several factors linked with a weaker response:
- older age, with response falling as age rises
- male sex, obesity, smoking and diabetes
- chronic medical conditions, including kidney disease and dialysis
- a weakened immune system from illness or treatment
- genetic factors
Low antibody years after vaccination: waning, not always lost protection
Antibody levels fall over time after vaccination. CDC guidance states that people with a normal immune system who responded to the full course and are later found to have anti-HBs below 10 mIU/mL remain protected, because immune memory persists. It also states that routine boosters and repeat antibody checks are not generally recommended for people with normal immune function.
The difficulty is that a test taken many years later cannot always show whether someone responded in the first place. CDC notes that testing healthcare workers years after vaccination might not distinguish non-responders from people whose levels have simply waned. This is why employers sometimes ask for an extra vaccine dose and a retest. Some groups, such as people on dialysis, follow a different plan with regular checks.
What happens next: repeat course and retest in outline
The exact plan, vaccine type and number of doses are decided by your clinician or occupational health service. In outline, CDC guidance describes these steps:
- Low anti-HBs 1–2 months after a complete first course: a second complete course, then a retest 1–2 months after the final dose.
- Previously vaccinated, response never documented, now low: a single additional (challenge) dose may be given, then a retest. A protective result is taken as evidence of immune memory; if not, the rest of a second course usually follows.
- Still below the protective level after a second course: a test for HBsAg to check for current infection, which would need different care.
- Confirmed non-responder without infection: advice on avoiding exposure and the need for prompt post-exposure treatment if an exposure happens.
Healthcare workers and non-response
Healthcare and public-safety workers who may be exposed to blood are among the groups for whom CDC recommends checking anti-HBs after vaccination. The NHS notes that healthcare workers whose blood tests show three doses have not given enough protection may be offered further doses, and that employers should organise vaccination for people at risk through their work.
Rules for staff who remain non-responders vary between employers and countries. Ask your occupational health service what your result means for your role, how exposures will be handled, and how your status is recorded. Keep a copy of your vaccine dates and results.
Questions to ask your clinician or occupational health team
Take your vaccine record and all hepatitis B results to the appointment. These questions can help:
- Was my test done soon after a vaccine course, or years later?
- Do my records show that I ever had a protective result?
- Have HBsAg and core antibody (anti-HBc) been checked, and what were they?
- Do I need a single extra dose, a full second course, or no further vaccine?
- When should I be retested, and who will tell me the result?
- If I stay a non-responder, what should I do straight away after a needlestick or splash?
- Could any health condition or medicine be lowering my response?
How comparing similar cases on SameCase can help you prepare
On SameCase, patients and verified doctors share de-identified cases. Reading how others with a low anti-HBs result described their timing, records and next steps may help you notice details to bring up, such as whether you ever had a post-course test. Other people's cases cannot tell you whether you are protected. Use them to prepare questions, and rely on your own clinician or occupational health team for decisions.
Sources and further reading
- CDC MMWR: Prevention of Hepatitis B Virus Infection in the United States – ACIP Recommendations (2018)
- CDC Pink Book: Hepatitis B chapter (page updated May 2024)
- NHS: Hepatitis B vaccine, boosters and how well it works (reviewed March 2024)
- NHS: Hepatitis B symptoms and prevention (reviewed November 2025)
- MedlinePlus: Hepatitis panel and the anti-HBs marker (updated January 2025)
For patients & caregivers
Share your case and learn from others
Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.